Indication

Primary hypogonadism due to orchitis

Primary hypogonadism due to orchitis is an acquired form of male hypergonadotropic hypogonadism characterized by intrinsic testicular failure following severe inflammation or infection of the testes, most commonly viral mumps or severe bacterial epididymo-orchitis. Read more about Primary hypogonadism due to orchitis

106 drugs 67 manufacturers

Advertisement

Drugs that treat it

Common Primary hypogonadism due to orchitis therapies.

Showing 82–90 of 106 drugs

TESTOSTERONE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
BRYANT RANCH PR

TESTOSTERONE CYPIONATE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
BRYANT RANCH PR

TESTOSTERONE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
STRIDES PHARMA

TESTOSTERONE CYPIONATE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
ENOVACHEM MANUF

TESTOSTERONE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
TEVA USA

TESTOSTERONE CYPIONATE

ANDROGENS/ANABOLIC STEROIDS·GONADOTROPIN RELEASING FACTOR DEFICIENCY·+9
American Regent
Filter & compare in the drug finder →Opens the drug finder with Primary hypogonadism due to orchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Primary hypogonadism due to orchitis.

Primary hypogonadism due to orchitis is an acquired form of male hypergonadotropic hypogonadism characterized by intrinsic testicular failure following severe inflammation or infection of the testes, most commonly viral mumps or severe bacterial epididymo-orchitis.

The inflammatory injury damages the testicular parenchyma, resulting in destruction or dysfunction of androgen-producing Leydig cells and seminiferous tubules.

Clinically and pathophysiologically, this condition manifests in adult or adolescent males with subnormal circulating testosterone concentrations accompanied by a compensatory elevation in serum gonadotropins, specifically luteinizing hormone and follicle-stimulating hormone.

Affected patients typically present with testicular atrophy, reduced libido, erectile dysfunction, fatigue, and impaired spermatogenesis.

Personalize your experience

Follow Primary hypogonadism due to orchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it